Rothschild & Co Upgrades CME Group to Buy, Raises Price Target to $323
سي إم إي إنك
CME Group Inc. Class A CME | 0.00 |
Rothschild & Co analyst Simon Clinch upgrades CME Group (NASDAQ:
CME) from Neutral to Buy and raises the price target from $316 to $323.
